Articles

An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to

Effects of Exenatide versus Sitagliptin on Postprandial Glucose, Insulin, and Glucagon Secretion, Gastric Emptying, and Caloric Intake: A Randomized, Crossover Study

Elevated levels of interleukin-1 receptor antagonist (IL-1Ra), a natural inhibitor of interleukin-1 beta, precedes the onset of Type 2 diabetes

Insulin Use and Exercise, Part 2: Longer-Acting, Basal Insulins

Understanding barriers to diabetes self-care is the first step in facilitating providers to identify their role in enabling patients to

Treatment with the glitazone class of diabetes drugs leads to a “modest” increase in the risk of diabetic macular edema (DME)-a common complication that can lead to

A new study has uncovered evidence that pregnant women with periodontal (gum) disease face an increased risk of developing gestational diabetes even if they

Clinical trials overseen by the University of Miami’s Diabetes Research Center show dramatic results in treatment of Type 2 diabetes. Stem cells developed into pancreatic cells and…

Eating red and processed meat is associated with increases in total mortality, cancer mortality, and cardiovascular disease mortality rates, according to the results of a large, prospective study. During 10 years of follow-up, 47,976 men and 23,276 women….

Adults who have impaired glucose tolerance but who are not considered diabetic are at elevated risk for heart disease and can benefit from….